These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7581985)

  • 1. Collagen metabolism in two types of autosomal dominant osteopetrosis during stimulation with thyroid hormones.
    Bollerslev J; Thomas S; Grodum E; Brixen K; Djøseland O
    Eur J Endocrinol; 1995 Nov; 133(5):557-63. PubMed ID: 7581985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine.
    Bollerslev J; Ueland T; Grodum E; Haug E; Brixen K; Djøseland O
    Eur J Endocrinol; 1998 Jul; 139(1):29-35. PubMed ID: 9703375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal responsiveness to thyroid hormone is not altered at menopause.
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    Bone; 1996 Nov; 19(5):557-64. PubMed ID: 8922657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.
    Brahm H; Ljunggren O; Larsson K; Lindh E; Ljunghall S
    Calcif Tissue Int; 1994 Dec; 55(6):412-6. PubMed ID: 7895178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males.
    Gram J; Junker P; Nielsen HK; Bollerslev J
    Bone; 1996 Jun; 18(6):539-44. PubMed ID: 8805994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.
    Miyakawa M; Tsushima T; Demura H
    Endocr J; 1996 Dec; 43(6):701-8. PubMed ID: 9075610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A; Colak O; Alatas O; Efe B
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.
    Legovini P; De Menis E; Da Rin G; Roiter I; Breda F; Artuso V; Di Virgilio R; Conte N
    Horm Metab Res; 1994 Jul; 26(7):334-7. PubMed ID: 7959610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triiodothyronine stimulates urinary excretion of calcium and hydroxyproline in autosomal dominant osteopetrosis.
    Bollerslev J; Nielsen HK; Kvetny J; Mosekilde L
    Bone; 1988; 9(4):205-8. PubMed ID: 3166837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of TGF-beta and fibronectin in autosomal dominant osteopetrosis in relation to underlying mutations and well-described murine counterparts.
    Bollerslev J; Ueland T; Odgren PR
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):163-71. PubMed ID: 14696964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced serum levels of carboxy-terminal propeptide of human type I procollagen in a family with type I-A osteogenesis imperfecta.
    Minisola S; Piccioni AL; Rosso R; Romagnoli E; Pacitti MT; Scarnecchia L; Mazzuoli G
    Metabolism; 1994 Oct; 43(10):1261-5. PubMed ID: 7934978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas.
    Osella G; Terzolo M; Reimondo G; Piovesan A; Pia A; Termine A; Paccotti P; Angeli A
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3303-7. PubMed ID: 9329358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate.
    de la Piedra C; Rapado A; Díaz Diego EM; Díaz Martín MA; Aguirre C; López Gavilanes E; Díaz Curiel M
    Calcif Tissue Int; 1996 Aug; 59(2):95-9. PubMed ID: 8687976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery.
    Minisola S; Romagnoli E; Scarnecchia L; Rosso R; Pacitti MT; Scarda A; Mazzuoli G
    Eur J Endocrinol; 1994 Jun; 130(6):587-91. PubMed ID: 8205259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
    Sartorio A; Conti A; Monzani M
    Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.